23 results
8-K
EX-10.2
ANVS
Annovis Bio Inc
21 Mar 24
Entry into a Material Definitive Agreement
5:23pm
for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which
424B5
ANVS
Annovis Bio Inc
18 Mar 24
Prospectus supplement for primary offering
10:00pm
December 31 2022 which is incorporated by reference in this prospectus supplement, there were material amounts inappropriately classified as research … and development expense which should have been classified as prepaid assets and other assets. We are taking steps to remediate the material weakness
424B5
ANVS
Annovis Bio Inc
18 Mar 24
Prospectus supplement for primary offering
8:51pm
31 2022 which is incorporated by reference in this prospectus supplement, there were material amounts inappropriately classified as research … and development expense which should have been classified as prepaid assets and other assets. We are taking steps to remediate the material weakness
8-K
EX-10.2
ANVS
Annovis Bio Inc
15 Mar 24
Entry into a Material Definitive Agreement
5:22pm
leasing or similar arrangement which, in connection with GAAP, consistently applied for the periods covered thereby, is classified as a capital lease
424B5
v6njq
1 Nov 23
Prospectus supplement for primary offering
12:24pm
424B5
05224oic dj5
30 Oct 23
Prospectus supplement for primary offering
5:27pm
10-K
e9hhyz68z7bdvp8m
25 Mar 20
Annual report
4:45pm
424B4
ign6koinjw
30 Jan 20
Prospectus supplement with pricing info
6:07am
S-1/A
yz7tykk9 42y7clt
8 Aug 19
IPO registration (amended)
5:23pm
S-1
mrq6hq h6s
2 Jul 19
IPO registration
9:15pm
CORRESP
smovh1r 8do4met
2 Jul 19
Correspondence with SEC
12:00am